Table 5. Summary of four studies investigating miRNA expression in human cell cultures after ADs use.
Abbreviations: LCLs - human lymphoblastoid cell lines, miRNA - microRNA
Author/year | Population | Treatment | Sample | MicroRNAs after treatment |
Lopez et al. [14], 2017 (Canada) | Human neural progenitor cells | Duloxetine | Human neural progenitor cells | Reduced: miR-146a-5p, miR-146b-5p, miR-24-3p, and miR-425-3p |
Oved et al. [62], 2012 (Israel) | LCLs from 80 healthy adult female donors | Paroxetine | LCLs | MiR-151-3p: increased sensitivity to paroxetine MiR-212, miR-132, miR-30b*, let-7b and let-7c also differed between paroxetine and control groups |
Angelucci et al. [63], 2011 (Italy) | Cell cultures and control cultures | Paroxetine | Human glioblastoma-astrocytoma; | 6 h and 12 h of incubation Increased: miR-30a 24h of incubation: miR-30a expression returned to levels comparable to untreated cells |
Oved et al. [64], 2013 (Israel) | Cell cultures and control cultures | 1mM paroxetine for 21 days X phosphate-buffered saline | Cell cultures (human) | Reduced: miR-221 and miR-22 |